News
Liver fluke test: Developing a rapid test to support farmers in response to antihelminthic resistance
“We are delighted that what started as a research tool is now being developed as a practical diagnostic test for farmers and vets, to support strategic control for this common, devastating disease.” Dr Tessa Walsh,…
New CEO at GADx, Dr Mark Street-Docherty
It is with great pleasure that Mologic Ltd t/a Global Access Diagnostics (GADx), announces the appointment of our new CEO, starting 1st February 2024, Dr Mark Street-Docherty. Mark brings with him enormous experience of leading…
How in-field diagnostics can reduce waste on farms and promote sustainable agriculture
Did you know that on a global scale up to 40% of crops are lost to pests and diseases? This article provides an overview on the waste associated with farming, contributing to global food insecurity,…
GADx reintroduces IT LEISH, the rapid diagnostic test for visceral leishmaniasis
Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics, today announced the launch of IT LEISH, a rapid diagnostic test (RDT) for visceral leishmaniasis (VL). The company acquired the manufacturing rights for…
COVID-19 Rapid Antigen Self-Test, COVI-Go™, receives FDA Emergency Use Authorization for home use
Mologic Inc., the US subsidiary of Global Access Diagnostics (GADx), a leading developer of lateral flow and rapid diagnostic technologies, products and services, announced today that its proprietary COVI-Go™ SARS-CoV-2 Ag Self-Test received Emergency Use…
Detecting multiple diseases at once: EU-funded DIDIDA project develops a cost-effective mobile based solution in Africa
The Digital Innovations and Diagnostics for Infectious Diseases in Africa (DIDIDA) had its official kick-off at the Strathmore University. DIDIDA is an ambitious project to develop reliable, low-cost, mobile phone-connected tests to help detect multiple…
GADx acquires manufacturing rights for IT LEISH rapid diagnostic test from Bio-Rad Laboratories
Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics and driving local manufacturing, today announced it has acquired the manufacturing rights for the IT LEISH rapid diagnostic test (RDT) for visceral leishmaniasis…
GADx formed to expand affordable access to advanced rapid diagnostic technologies
Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global health, today formally introduced its first portfolio company, Global Access Diagnostics (GADx). GADx has been created to address gaps in…
Mologic partners with FINDdx for schistosomiasis rapid test
Neglected Tropical Diseases affect more than one billion people worldwide, in some of the poorest areas. According to the World Health Organisation, schistosomiasis is a disease of poverty that leads to chronic ill health and…
Mologic and Alamar Biosciences collaborate to develop a next generation COVID-19 antigen test
Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Mologic, Ltd. (Mologic), part of the recently formed social enterprise Global…